---
title: "Crinetics Shares Edge Up After Vertex Announces $10 Billion Acquisition"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292109907.md"
description: "Crinetics edges up 0.3% after-hours to record high as Vertex announces $10B all-cash acquisition at $85/share, deal expected Q3 2026."
datetime: "2026-07-08T20:12:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292109907.md)
  - [en](https://longbridge.com/en/news/292109907.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292109907.md)
generator: "portal-rs"
---

# Crinetics Shares Edge Up After Vertex Announces $10 Billion Acquisition

Crinetics Pharmaceuticals(CRNX.US) 盘后涨**0.3%**，现报**83.49**美元，股价创新高。

消息面上，Vertex Pharmaceuticals 宣布以约**100 亿**美元现金收购 Crinetics，收购价为每股**85**美元，交易预计于 2026 年第三季度完成。

此次收购将为 Vertex 带来两款内分泌疾病领域药物：已获批的肢端肥大症治疗药物 PALSONIFY，以及处于三期临床阶段的先天性肾上腺皮质增生症候选药物 Atumelnant。

### Related Stocks

- [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md)

## Related News & Research

- [Crinetics Pharmaceuticals held special shareholder meeting on merger proposal vote](https://longbridge.com/en/news/297368932.md)
- [Bank of America Corp DE Sells 85,189 Shares of Crinetics Pharmaceuticals, Inc. $CRNX](https://longbridge.com/en/news/296069006.md)
- [Crinetics Pharmaceuticals, Inc. $CRNX Shares Bought by Dimensional Fund Advisors LP](https://longbridge.com/en/news/294926392.md)
- [Crinetics Pharmaceuticals, Inc. $CRNX Shares Bought by Glenmede Trust Co. NA](https://longbridge.com/en/news/295207108.md)
- [CRNX: Pipeline advances in acromegaly, CAH, and NETs, with strong financial runway into 2030](https://longbridge.com/en/news/293389069.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**